MedTech Acquisition
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. MedTech Acquisition's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49% to $18,511,000. Profit margin reached -319%. Total operating expenses were $70,056,000.

Profit Margin

MedTech Acquisition Corporation (NASDAQ:MTACU): Profit margin
2020 5.43M -31.83M -585.76%
2021 8.40M -28.84M -343.35%
2022 12.39M -47.18M -380.6%
2023 18.51M -59.03M -318.93%

MTACU Income Statement (2020 – 2023)

2023 2022 2021 2020
Revenue
Revenue
18.51M12.39M8.40M5.43M
Cost of revenue
2.60M2.25M1.19M2.19M
Gross profit
15.90M10.14M7.20M3.23M
Operating exp.
Research and development
29.51M21.35M14.22M15.82M
Selling and marketing
17.03M12.73M8.26M6.18M
Total operating expenses
70.05M46.57M31.24M29.02M
Operating income
-54.15M-36.43M-24.03M-25.64M
Other income (expenses), net
-4.87M-10.91M-3.04M-6.18M
Income before tax
-59.02M-47.17M-28.84M-31.82M
Income tax expense
9K9K3K4K
Net income
-59.03M-47.18M-28.84M-31.83M
Earnings per share
Basic EPS
-6.73-1.59-0.92-1.04
Diluted EPS
-6.73-1.59-0.92-1.04
Data source